Pular para o conteúdo
Menu
Mix Vale

Semaglutide loses exclusivity after 20 years and paves the way for national versions of Ozempic and Wegovy

Carolina Costa
Por 4 min de leitura
Compartilhe
Semaglutida, caneta emagrecedora
Foto: Semaglutida, caneta emagrecedora - Edugrafo/ Shutterstock.com

The patent for semaglutide, the active ingredient in the medicines Ozempic and Wegovy, expires in Brasil on March 20, 2026. The Danish laboratory Outras companies can now develop and register equivalent versions, as long as they are approved by Agência Nacional of Vigilância Sanitária (Anvisa). The measure comes after frustrated attempts by the pharmaceutical company to extend the deadline, rejected by the Superior Tribunal of Justiça (STJ).

Publicidade

Semaglutide belongs to the class of GLP-1 analogues, which simulate the natural hormone to control blood sugar and promote satiety. The medication is indicated for type 2 diabetes and obesity, reducing caloric intake through mechanisms in the pancreas, stomach and brain. The expiration of the patent allows national and foreign pharmaceutical companies to begin local production. Anvisa has already received multiple registration requests to analyze quality, safety and equivalence to the original versions.

Ministério of Saúde requested priority in the evaluation of these products to expand access to treatment. Empresas like EMS, which already operates in the segment, prepares launches as soon as they obtain regulatory approval. Competition should intensify the market and influence the prices charged in pharmacies.

Publicidade
Ozempic - Mounjaro - Canetinha
Ozempic – Mounjaro – Canetinha – Foto: Matthew Fowler/istockphoto.com

Liraglutide now off patent since 2025

Liraglutide, the active ingredient in Saxenda, lost patent protection in March 2025. The substance was the first in its class to demonstrate a significant effect on weight loss. Brazilian pharmaceutical company EMS launched Olire, a national version based on liraglutide, available since August 2025. The product is indicated for obesity and type 2 diabetes, with daily administration.

The Olire represents a more affordable alternative to the original Saxenda. Estudos clinicians indicate an average loss of around 8% of body weight in one year of use. The entry of this version into the Brazilian market expanded the options for patients seeking injectable treatments.

The availability of Olire demonstrates the practical impact of ending patents. Outras companies also come forward with similar registrations for liraglutide. Local production contributes to greater supply and potential cost reduction.

Tirzepatide maintains protection until 2036

Publicidade

Tirzepatide, the active ingredient in Mounjaro, from Eli Lilly, remains on patent until June 2036 in Brasil. Essa molecule acts as a double agonist, simulating both GLP-1 and GIP, intestinal hormones that regulate appetite and metabolism. The medicine represents a more recent generation of analogues, with significant results in weight reduction.

Studies show superior weight losses compared to previous molecules. The Mounjaro arrived on the Brazilian market in 2025 and remains exclusive to the original manufacturer. The long patent protection postpones the entry of generic or similar versions of this substance.

The difference in expiration dates reflects companies’ development and registration strategies. Enquanto semaglutide and liraglutide open space for immediate competition, tirzepatide maintains exclusivity for another decade.

Anvisa prioritizes analyzes to expand access

Anvisa has been receiving and evaluating registration applications for semaglutide-based medicines since the end of the patent was announced. Pelo minus 17 requests related to weight loss pens are being processed, including semaglutide and liraglutide. The agency verifies biopharmaceutical equivalence, purity and stability of proposed formulations.

The process involves comparative testing with the reference product. The prioritization requested by Ministério of Saúde aims to speed up approvals and incorporate options into the SUS or popular pharmacies. Especialistas monitor the arrival of the first approved versions throughout 2026.

The expectation is for greater availability in pharmacies after regulatory releases. Pacientes with type 2 diabetes and obesity can count on more therapeutic alternatives in the coming months.

Expanding slimming pen market

The segment of injectable medicines for obesity and diabetes has grown by Brasil since the introduction of pens. Semaglutide has driven significant sales in recent years. With the end of exclusivity, analysts predict an increase in supply and adjustments in prices charged.

National pharmaceutical companies invest in production capacity to meet demand. Local production reduces dependence on imports and strengthens the Brazilian pharmaceutical industry. Competition benefits consumers with more varied options.

The use of these medications requires a medical prescription and professional monitoring. Indicações follow established protocols for safety and efficacy in treatment.

Publicidade

Carolina Costa é colaboradora da redação do Mix Vale, portal de notícias com cobertura de Brasil e mundo. Produz conteúdo nas editorias de economia e benefícios, com foco em informação de serviço para o leitor brasileiro. Escreve para o portal desde 2019. Formação: Administração

Notícias relacionadas

Mais lidas

  1. Ciência

    Meteoro no Nordeste: bólido cruza o céu de cinco estados às 21h34 e mobiliza buscas por fragmentos na Paraíba

  2. Caixa Econômica Federal

    Pé-de-Meia paga parcela de R$ 1.000,00 a aprovados no ensino médio de 2026 entre fevereiro e março de 2027

  3. Política

    Com obstrução parcial no intestino, Jair Bolsonaro é internado no hospital DF Star em Brasília

  4. INSS

    Recuperação da senha Gov.br pelo celular exige reconhecimento facial ou código por SMS para o Meu INSS

  5. EUA

    Terremoto em Los Angeles atinge magnitude 4,2 e causa tremores leves em Commerce na madrugada

  6. Matéria Publicitária

    MineMV é o novo jogo grátis de construir com blocos; veja como jogar e liberado para todas as idades

  7. Política

    Regulamentação da escala 5×2 pelo governo encarece cálculo da hora extra a partir de 16 de dezembro

  8. Santa Catarina

    Acidente de trânsito na SC-108 envolve carro e moto e deixa motociclista morto em São Ludgero

  9. Mundo

    Jornalista italiano Corrado Augias morre aos 91 anos; presidente da Itália lamenta a perda

  10. Loterias

    Rendimento de R$ 40 milhões da Mega-Sena 3088 chega a R$ 337 mil por mês no Tesouro Direto